Sexcord/ stromal ovarian tumors natural history, complications and prognosis: Difference between revisions
Line 36: | Line 36: | ||
*Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as excellent<ref name="pmid16050568">{{cite journal |vauthors=Schneider DT, Calaminus G, Harms D, Göbel U |title=Ovarian sex cord-stromal tumors in children and adolescents |journal=J Reprod Med |volume=50 |issue=6 |pages=439–46 |date=June 2005 |pmid=16050568 |doi= |url=}}</ref> | *Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as excellent<ref name="pmid16050568">{{cite journal |vauthors=Schneider DT, Calaminus G, Harms D, Göbel U |title=Ovarian sex cord-stromal tumors in children and adolescents |journal=J Reprod Med |volume=50 |issue=6 |pages=439–46 |date=June 2005 |pmid=16050568 |doi= |url=}}</ref> | ||
*Most sexcord-stromal ovarian tumors present at a low tumor stage and also prognosis in these patients is excellent | *Most sexcord-stromal ovarian tumors present at a low tumor stage and also prognosis in these patients is excellent | ||
Patients with JGCT and SLCT show greater mitotic activity than do all those with other histologic types. Furthermore, high mitotic activity is associated with adverse outcome. | |||
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy]. | *The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy]. | ||
*[Subtype of disease/malignancy] is associated with the most favorable prognosis. | *[Subtype of disease/malignancy] is associated with the most favorable prognosis. |
Revision as of 02:33, 7 April 2019
Sexcord/ stromal ovarian tumors Microchapters |
Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Sexcord/ stromal ovarian tumors natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors natural history, complications and prognosis |
FDA on Sexcord/ stromal ovarian tumors natural history, complications and prognosis |
CDC on Sexcord/ stromal ovarian tumors natural history, complications and prognosis |
Sexcord/ stromal ovarian tumors natural history, complications and prognosis in the news |
Blogs on Sexcord/ stromal ovarian tumors natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of sexcord/ stromal ovarian tumors usually develop in the second/ third/ fourth decade of life, and start with symptoms such as:
- Adnexal mass
- Abdominal & pelvic symptoms
- Bloating
- Urinary urgency or frequency
- Dysphagia(difficulty eating) or feeling full quickly
- Pelvic or abdominal pain
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as excellent[1]
- Most sexcord-stromal ovarian tumors present at a low tumor stage and also prognosis in these patients is excellent
Patients with JGCT and SLCT show greater mitotic activity than do all those with other histologic types. Furthermore, high mitotic activity is associated with adverse outcome.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the subtypes of tumor[2]
- Sertoli-Leydig cell tumors have a 70 to 90 percent five-year survival overall and is mainly related to the stage and degree of histologic differentiation.
References
- ↑ Schneider DT, Calaminus G, Harms D, Göbel U (June 2005). "Ovarian sex cord-stromal tumors in children and adolescents". J Reprod Med. 50 (6): 439–46. PMID 16050568.
- ↑ Elashry R, Hemida R, Goda H, Abdel-Hady e (2013). "Prognostic factors of germ cell and sex cord-stromal ovarian tumors in pediatric age: 5 years experience". J. Exp. Ther. Oncol. 10 (3): 181–7. PMID 24416992. Vancouver style error: initials (help)